Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

The field of epilepsy research has rapidly evolved with an appreciation that seizures arise from dysfunctions in distributed ...

A novel mathematical approach enables the identification of brain regions whose connectivity shifts in autism or aging, ...

It is a central question in neuroscience to understand how different regions of the brain interact, how strongly they "talk" ...

The brain’s internal communication patterns change over the course of our lives and also differ in people with certain neurological conditions. Understanding these processes is one of the central ...

Begin the new year by supporting your body's microbiome with Invivo. As you enter a season of renewal, nurturing your ...

Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people are already affected worldwide, and the number is continually climbing. Men ...

Neurostimulation devices market was valued at US$ 9.84 billion in 2024 and is projected to hit the market valuation of US$ 22.64 billion by 2033 at a CAGR of 9.7% during the forecast period 2025–2033.

In findings that raise a variety of questions about how our brains work, and even about the nature of consciousness, UC Santa ...

In South Dakota, health care challenges are shaped by geography, an aging population, workforce shortages, chronic diseases ...